SANOFI
10 articole · RSS
Zentiva Romania Sees Lower Profit In First Quarter
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported net profit of 12 million lei (EUR2.7 million) for the first quarter of 2015, down 15.5% compared with RON14.2 million in the year-earlier period.
Sanofi Romania Set To Launch Four New Products In 2015
The non-prescription drug (OTC) market rose by over 10% last year, but the average annual growth pace will go down to 4-5% as people’s incomes are not expected to register significant increa...
Sanofi Romania, First Tenant Of 2nd Building Of Office Compound Green Court
Drug maker Sanofi Romania is the first tenant of the second building of Bucharest-based office compound Green Court developed by Swedish real estate developer and construction company Skansk...
Exports Up To 25% Of Zentiva Bucharest’s Production
Exports reached 25% of the production of Zentiva (SCD.RO) plant in Bucharest, a unit of French pharmaceutical group Sanofi, frm just 15% in 2013.
Algocalmin Brand Generates 16% Of Sanofi Romania's Sales
Algocalmin, one of Romania’s oldest medicine drug brands, registered sales of more than 10 million packs between April 2013 and March 2014, flat from the year-earlier period.
Sanofi Transfers Production Or Packaging Of Dozens Of Medicines To Zentiva Romania
French pharmaceutical group Sanofi transferred the production or packaging of 22 medicines to its Zentiva plant in Romania in 2013 and other 30 new products are about to be transferred, the...
Stress Costs Romanians EUR12M A Year
“Stress is part of life. The problem is how you cope with it. There is a level of positive stress, generating good, motivational pressure, but there are problems when a high level of stress...
Sanofi Wants To Double Exports, Launch At Least 15 New Products In 2014
Sanofi, the largest pharmaceutical company in Romania, which owns the Zentiva plant (SCD.RO) in Bucharest, estimates exports could reach 30% of its production volume in 2013, double the 2012...
Zentiva To Boost Exports To 50% Of Production
The exports of Sanofi Romania’s Zentiva plant in Bucharest have reached 14% of its production, from 8% last year, says Christophe Gourlet, the general manager of the company.